Detalles de la búsqueda
1.
"I couldn't carry on taking a drug like that": A qualitative study of patient perspectives on side effects from rheumatology drugs.
Rheumatology (Oxford)
; 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38613847
2.
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Ann Rheum Dis
; 82(6): 773-787, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953263
3.
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids.
Rheumatology (Oxford)
; 62(5): 1824-1833, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36165675
4.
2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice.
Ann Rheum Dis
; 80(6): 707-713, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33355152
5.
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group.
Ann Rheum Dis
; 80(2): 242-249, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33055082
6.
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Ann Rheum Dis
; 80(1): 71-87, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33158881
7.
Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count.
Rheumatology (Oxford)
; 60(11): 5239-5246, 2021 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33682887
8.
Barriers and potential solutions in the recruitment and retention of older patients in clinical trials-lessons learned from six large multicentre randomized controlled trials.
Age Ageing
; 50(6): 1988-1996, 2021 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324628
9.
Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group.
Ann Rheum Dis
; 79(10): 1269-1276, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32606042
10.
2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis.
Ann Rheum Dis
; 79(1): 61-68, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31300458
11.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Ann Rheum Dis
; 79(6): 685-699, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31969328
12.
Patients' experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set.
Rheumatology (Oxford)
; 2019 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30843587
13.
Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Aging Clin Exp Res
; 31(7): 905-915, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30993659
14.
The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission.
Ann Rheum Dis
; 76(5): 855-861, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27903508
15.
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis.
Ann Rheum Dis
; 76(6): 1101-1136, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28298374
16.
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 76(6): 1113-1136, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28283512
17.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
Ann Rheum Dis
; 76(6): 960-977, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28264816
18.
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update.
Ann Rheum Dis
; 75(1): 16-22, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25990290
19.
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.
Ann Rheum Dis
; 75(1): 3-15, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25969430
20.
Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study.
BMC Musculoskelet Disord
; 17(1): 442, 2016 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27769224